- Home
- ALLT vs AQST Comparison
ALLT vs AQST Comparison
Compare ALLT & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLT
- AQST
- Stock Information
- Founded
- ALLT 1996
- AQST 2004
- Country
- ALLT Israel
- AQST United States
- Employees
- ALLT N/A
- AQST N/A
- Industry
- ALLT Telecommunications Equipment
- AQST Biotechnology: Pharmaceutical Preparations
- Sector
- ALLT Telecommunications
- AQST Health Care
- Exchange
- ALLT Nasdaq
- AQST Nasdaq
- Market Cap
- ALLT 342.5M
- AQST 390.4M
- IPO Year
- ALLT 2006
- AQST 2018
- Fundamental
- Price
- ALLT $7.79
- AQST $3.98
- Analyst Decision
- ALLT Buy
- AQST Strong Buy
- Analyst Count
- ALLT 1
- AQST 6
- Target Price
- ALLT N/A
- AQST $10.67
- AVG Volume (30 Days)
- ALLT 509.7K
- AQST 1.3M
- Earning Date
- ALLT 08-14-2025
- AQST 08-11-2025
- Dividend Yield
- ALLT N/A
- AQST N/A
- EPS Growth
- ALLT N/A
- AQST N/A
- EPS
- ALLT N/A
- AQST N/A
- Revenue
- ALLT $95,342,000.00
- AQST $44,132,000.00
- Revenue This Year
- ALLT $9.08
- AQST N/A
- Revenue Next Year
- ALLT $26.37
- AQST $51.62
- P/E Ratio
- ALLT N/A
- AQST N/A
- Revenue Growth
- ALLT 4.74
- AQST N/A
- 52 Week Low
- ALLT $2.75
- AQST $2.12
- 52 Week High
- ALLT $10.77
- AQST $5.80
- Technical
- Relative Strength Index (RSI)
- ALLT 51.15
- AQST 52.27
- Support Level
- ALLT $7.05
- AQST $3.81
- Resistance Level
- ALLT $8.10
- AQST $4.26
- Average True Range (ATR)
- ALLT 0.40
- AQST 0.24
- MACD
- ALLT 0.04
- AQST -0.02
- Stochastic Oscillator
- ALLT 70.48
- AQST 50.00
About ALLT Allot Ltd.
Allot Ltd is a provider of network intelligence and security solutions for service providers and enterprises. The company's solutions are deployed globally for network and application analytics, traffic control and shaping, and network-based security services. The firm's multi-service platforms are deployed by mobile, fixed, and cloud service providers and enterprises. The company has a customer base in Europe, Asia and Oceania, the Americas, the Middle East, and Africa.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.